Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Horie

Showing results (211-220 of 428) with videos related to

Pageof 43
Sort By:
Biochemical and Biophysical Research Communications|November 19, 2003
Insulinotropic action of glutamate is dependent on the inhibition of ATP-sensitive potassium channel activities in MIN 6 beta cellsHidenori Katsuta, Sachihiko Ozawa, Tomonori Ninomiya, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 30, 2018
Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sistersShuhei Fujita, Keigo Nishida, Hitoshi Irabu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 29, 2016
Inter-Facility Transfer vs. Direct Admission of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionKenji Nakatsuma, Hiroki Shiomi, Takeshi Morimoto, et al.
The Journal of General Physiology|April 21, 2022
Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2Nagomi Kurebayashi, Takashi Murayama, Ryosaku Ota, et al.
Internal Medicine (Tokyo, Japan)|February 3, 2016
Multigenerational Inheritance of Long QT Syndrome Type 2 in a Japanese FamilyMari Ichikawa, Seiko Ohno, Yusuke Fujii, et al.
Journal of Arrhythmia|October 19, 2019
Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: Insights into syncope after drinking alcoholQi Wu, Hideki Hayashi, Daiki Hira, et al.
Journal of the American College of Cardiology|April 23, 2003
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patientsTetsuya Matsumoto, Kazuo Minai, Hajime Horie, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failureMasanori Fujii, Atsuyuki Wada, Masato Ohnishi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2019
Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense MutationYoshihiro Nozaki, Yoshiaki Kato, Kiyoshi Uike, et al.
International Journal of Cardiology|May 8, 2009
A novel SCN5A mutation associated with the linker between III and IV domains of Nav1.5 in a neonate with fatal long QT syndromeKenichiro Yamamura, Jun Muneuchi, Kiyoshi Uike, et al.
Pageof 43

Showing results (211-220 of 428) with videos related to

Sort By:
Pageof 43
Biochemical and Biophysical Research Communications|November 19, 2003
Insulinotropic action of glutamate is dependent on the inhibition of ATP-sensitive potassium channel activities in MIN 6 beta cellsHidenori Katsuta, Sachihiko Ozawa, Tomonori Ninomiya, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|August 30, 2018
Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sistersShuhei Fujita, Keigo Nishida, Hitoshi Irabu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 29, 2016
Inter-Facility Transfer vs. Direct Admission of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionKenji Nakatsuma, Hiroki Shiomi, Takeshi Morimoto, et al.
The Journal of General Physiology|April 21, 2022
Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2Nagomi Kurebayashi, Takashi Murayama, Ryosaku Ota, et al.
Internal Medicine (Tokyo, Japan)|February 3, 2016
Multigenerational Inheritance of Long QT Syndrome Type 2 in a Japanese FamilyMari Ichikawa, Seiko Ohno, Yusuke Fujii, et al.
Journal of Arrhythmia|October 19, 2019
Genetic variants of alcohol-metabolizing enzymes in Brugada syndrome: Insights into syncope after drinking alcoholQi Wu, Hideki Hayashi, Daiki Hira, et al.
Journal of the American College of Cardiology|April 23, 2003
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patientsTetsuya Matsumoto, Kazuo Minai, Hajime Horie, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failureMasanori Fujii, Atsuyuki Wada, Masato Ohnishi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 26, 2019
Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense MutationYoshihiro Nozaki, Yoshiaki Kato, Kiyoshi Uike, et al.
International Journal of Cardiology|May 8, 2009
A novel SCN5A mutation associated with the linker between III and IV domains of Nav1.5 in a neonate with fatal long QT syndromeKenichiro Yamamura, Jun Muneuchi, Kiyoshi Uike, et al.
Pageof 43